Evaluation of Anthropometric Measurements, Arterial Stiffness, and ECG Parameters in Alopecia Areata Patients

November 2025 in “ Medicina ”

Esra Pancar Yüksel, Gökhan Şahin, Mehmet Murat Şahin, Serhat Karadavut, Serkan Yüksel, Fatma Aydın

alopecia areata AA anthropometric measurements arterial stiffness ECG parameters cardiovascular risk markers body fat mass visceral fat rating

Studysummary This study found that patients with alopecia areata had a lower heart rate compared to healthy controls and showed disease-severity-related changes in body composition, though the clinical importance of these findings is still unclear. Our plain-language summary of this paper — not a Tressless recommendation.

This study compared 50 alopecia areata (AA) patients with 50 healthy controls to assess cardiovascular risk markers. It found no significant differences in anthropometric measurements or arterial stiffness between the groups, but AA patients had a lower heart rate. Among AA patients, those with moderate-to-severe disease had lower body fat mass and visceral fat ratings compared to those with mild AA. The study suggests AA may be linked to changes in adiposity but not to increased arterial stiffness or ECG conduction issues. The clinical significance of these findings is uncertain, and larger studies are needed to explore the potential cardiovascular implications.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Tumor Necrosis Factor α Inhibitor-Induced Alopecia in Pediatric Patients: A Cohort of 20 Patients and Review of the Literature

3 citations , June 2025 in “Archives of Dermatological Research”

In a retrospective study, TNFα inhibitor-induced alopecia was observed in pediatric patients, primarily adolescents with inflammatory bowel diseases, with hair regrowth occurring in those who discontinued the therapy; this suggests that stopping these medications can improve drug-induced alopecia in children.

research European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata

4 citations , January 2024 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

This consensus statement outlines a treatment algorithm for alopecia areata, detailing systemic treatment indications and options, including EMA-approved medications baricitinib and ritlecitinib for severe cases, as well as other off-label treatments and adjuvant therapies like oral minoxidil.

research Is the Severity of Alopecia Areata Associated with Arterial Stiffness?

5 citations , November 2023 in “Journal of Research in Medical Sciences”

This study found that patients with AA who have more severe symptoms may have a higher risk of metabolic syndrome and arterial stiffness, suggesting a need for cardiometabolic disease screening.

research A Study of Correlation of Alopecia Areata and Metabolic Syndrome in Northwest Indian Population

5 citations , March 2023 in “International Journal of Trichology”

This study reported a similar prevalence of metabolic syndrome in patients with alopecia areata as in healthy controls, with no statistically significant differences observed.

Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study

research Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study

4 citations , November 2021 in “Journal of Clinical Medicine”

This study found no significant differences in certain proinflammatory protein levels between patients with alopecia areata and healthy controls but noted a potential association between disease severity and increased atherosclerosis risk.

research Comorbidities in Alopecia Areata: A Systematic Review and Meta-Analysis

100 citations , July 2018 in “Journal of The American Academy of Dermatology”

This study found that alopecia areata is linked with a higher prevalence of systemic and psychiatric diseases, suggesting that physicians should monitor for these potential comorbidities.

research Alopecia Areata: Overview and Insights from January 2018

290 citations , December 2017 in “Journal of The American Academy of Dermatology”

This article reviews the epidemiology, clinical evaluation, and pathogenesis of alopecia areata and highlights recent advancements, but it does not report new clinical findings.

research Development of Autoimmune Hair Loss Disease Alopecia Areata Is Associated with Cardiac Dysfunction in C3H/HeJ Mice

18 citations , April 2013 in “PLOS ONE”

This study found that in a mouse model, alopecia areata was associated with changes in heart structure, biochemistry, and gene expression linked to cardiac hypertrophy after ACTH exposure.

research Alopecia Areata Update

391 citations , January 2010 in “Journal of The American Academy of Dermatology”

This article reviews the clinical presentation and histopathologic features of alopecia areata and proposes a hypothesis for its development, but it reports no new clinical results.